Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 11.9B | 13.4B | 12.2B | 12.9B |
Cost of revenue | 4.9B | 6.1B | 5.3B | 5.9B |
Gross profit | 7.0B | 7.3B | 7.0B | 7.0B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 2.0B | 2.7B | 2.0B | 2.0B |
Other operating expenses | — | — | — | — |
Operating income | 5.0B | 4.6B | 5.0B | 5.0B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 883.3M | 900.5M | 968.6M | 961.2M |
Other income expense | 1.3B | 1.0B | 1.2B | 1.6B |
Pretax income | 5.4B | 4.7B | 5.2B | 5.6B |
Tax provision | 1.1B | 762.3M | 980.5M | 1.0B |
Net income | 4.3B | 4.0B | 4.2B | 4.6B |
Basic EPS | 0.9 | — | 0.9 | 1.0 |
Diluted EPS | 0.9 | — | 0.9 | 1.0 |
Basic average shares | 4.5B | — | 4.5B | 4.5B |
Diluted average shares | 4.5B | — | 4.5B | 4.5B |
EBITDA | 8.0B | 7.6B | 7.9B | 8.3B |
Net income from continuing op. | 4.3B | 4.0B | 4.2B | 4.6B |
Minority interests | -77.8M | -58.2M | -72.8M | -44.6M |
Preferred stock dividends | — | — | — | — |